QQ客服 官方微博 反馈留言

	Evaluating the efficacy, safety and tolerability of serelaxin when added to standard therapy in Asian patients with acute heart failure: The RELAX-AHF-ASIA trial
	Sato N., Lam C.S., Teerlink J.R., Greenberg B.H., Tsutsui H., Oh B.H., Zhang J., Hua T.A., Wang X.L., Ge J.
刊名	European Journal of Heart Failure
	2015
ISSN号	1388-9842
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4873281
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Sato N., Lam C.S., Teerlink J.R., Greenberg B.H., Tsutsui H., Oh B.H., Zhang J., Hua T.A., Wang X.L., Ge J.. Evaluating the efficacy, safety and tolerability of serelaxin when added to standard therapy in Asian patients with acute heart failure: The RELAX-AHF-ASIA trial[J]. European Journal of Heart Failure,2015.
APA	Sato N., Lam C.S., Teerlink J.R., Greenberg B.H., Tsutsui H., Oh B.H., Zhang J., Hua T.A., Wang X.L., Ge J..(2015).Evaluating the efficacy, safety and tolerability of serelaxin when added to standard therapy in Asian patients with acute heart failure: The RELAX-AHF-ASIA trial.European Journal of Heart Failure.
MLA	Sato N., Lam C.S., Teerlink J.R., Greenberg B.H., Tsutsui H., Oh B.H., Zhang J., Hua T.A., Wang X.L., Ge J.."Evaluating the efficacy, safety and tolerability of serelaxin when added to standard therapy in Asian patients with acute heart failure: The RELAX-AHF-ASIA trial".European Journal of Heart Failure (2015).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。